Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
84 USD | +4.10% | +9.10% | -13.54% |
12:39pm | KKR & Co, CrowdStrike, GoDaddy to Join S&P 500 Index on June 24 | MT |
Jun. 07 | BioMarin Pharmaceutical Reports New Data Affirming Long-Term Safety, Efficacy of Roctavian | MT |
Evolution of the average Target Price on BioMarin Pharmaceutical Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering BioMarin Pharmaceutical Inc.
Baird | |
Scotiabank | |
Wells Fargo Securities | |
Wedbush | |
BofA Securities | |
BMO Capital | |
UBS | |
Barclays | |
Cantor Fitzgerald | |
Morgan Stanley | |
Bernstein | |
Stifel Nicolaus | |
Canaccord Genuity | |
Citigroup | |
Piper Sandler | |
Guggenheim | |
Credit Suisse | |
Oppenheimer | |
SVB Securities LLC | |
Jefferies & Co. | |
JPMorgan Chase | |
RBC Capital Markets | |
Goldman Sachs | |
SVB Leerink | |
William Blair & Co. | |
Evercore ISI |
EPS Revisions
- Stock Market
- Equities
- BMRN Stock
- Consensus BioMarin Pharmaceutical Inc.